Open AccessRadiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer
Author(s) -
Giampaolo Perri,
Laura R. Prakash,
Huamin Wang,
Priya Bhosale,
Gauri R. Varadhachary,
Robert A. Wolff,
David R. Fogelman,
Michael J. Overman,
Shubham Pant,
Milind Javle,
Eugene J. Koay,
Joseph M. Herman,
Michael Kim,
Naruhiko Ikoma,
Ching Wei D. Tzeng,
Jeffrey E. Lee,
Matthew H. Katz
Publication year - 2019
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/sla.0000000000003442
Subject(s) - medicine , pancreatic cancer , response evaluation criteria in solid tumors , pancreatectomy , radiography , radiation therapy , cancer , radiology , pancreas , neoadjuvant therapy , adenocarcinoma , chemotherapy , progressive disease , breast cancer
We sought to identify potential radiologic and serologic markers of pancreatic tumor response to therapy, using pathologic major response (pMR) as the objective endpoint.